You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Development of a Biochemical Diagnosis for Creutzfeldt Jakob disease

    SBC: Amprion, Inc.            Topic: 101

    ABSTRACT Human prion diseases are infectious and invariably fatal neurodegenerative diseases including sporadic Creutzfeldt Jakob disease sCJD the most common form and variant CJD vCJD which is associated to consumption of cattle meat infected by bovine spongiform encephalopathy Currently there is not sensitive objective and non invasive biochemical diagnosis for these diseases and even ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  2. Proteolytic Imaging of Remodeling Myocardium

    SBC: Micro Vide, LLC            Topic: NHLBI

    DESCRIPTIONprovided by applicantProteolytic Imaging of Remodeling Myocardium Abstract Heart attacksi emyocardial infarction or MIoccur in more thanmillion patients annuallyAdvances in interventional and pharmacological therapies have dramatically improved survival following the initial MIand patients are often surviving acute MI with more extensive myocardial injuryConsequentlythe number of patien ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  3. Lab-on-a-Chip-Based System for Detection and Monitoring of Oral Cancer in Dental Settings

    SBC: SensoDX II, LLC            Topic: NIDCR

    DESCRIPTION provided by applicant Cancers of the oral cavity and pharynx are among the most serious cancers with approximately incidents globally In the US the year survival rate is approximately among the lowest for all forms of cancer Yet when diagnosed in the early stages with confinement to the primary site the rate increases dramatically to about Further cancers of the oral cavity are among t ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  4. IGF OT IGF DESIGNING METHODOLOGICALLY RIGOROUS ANIMAL STUDIES XDA EXPERIMENTAL DESIGN ASSISTANT N DA AUGUST AUGUST

    SBC: TIETRONIX SOFTWARE INC            Topic: NIDA

    Under this Small Business Innovation Research SBIR Phase II project Research Topic for "XDA eXperimental Design Assistant" the Contractor shall complete development of a platform to assist addiction and other life science investigators in designing in vivo animal experiments

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  5. Better Living After Stroke through Technology (BLAST)

    SBC: BRIGHTOUTCOME INC.            Topic: 600

    DESCRIPTION provided by applicant Stroke the leading cause of disability cognitive impairment and death in the US imposes significant financial and personal burden The residual effects of stroke affect many aspects of life not addressed by traditional rehabilitation treatments In particular persons with mild stroke typically defined as a stroke with no or sligh motor impairment and a high ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  6. Optimized lactoferrin for treatment of intracerebral hemorrhage

    SBC: Pharmareview Corporation            Topic: NINDS

    DESCRIPTION provided by applicant Intracerebral hemorrhage ICH is a major public health problem with highest mortality rate of all stroke subtypes and long term disability Since there are no available FDA approved therapies for ICH it is of enormous importance to establish effective treatment for this medical condition Following ICH the deposited blood is damaging initially via compression ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  7. VALIDATION OF AN IN VITRO ASSAY FOR ANDROGENIC ACTIVITY

    SBC: CERTICHEM INC            Topic: NIEHS

    DESCRIPTION provided by applicant Recent scientific investigations have shown that many chemicals used in plastics pharmaceuticals pesticides cosmetics food additives etc are endocrine disrupting chemicals EDCs EDCs interfere in various ways with hormones such as estrogens and androgens and can have significant adverse effects on many behavioral and physiological processes ED effec ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  8. Aminomethyl benzamides as novel anti Ebola agents

    SBC: Chicago Biosolutions, Inc.            Topic: NIAID

    Ebola EBOV and Marburg MARV viruses belong to the family Filoviridae and can cause fatal hemorrhagic fevers characterized by widespread tissue destruction with an incubation period of days Because of the safety concerns these viruses are designated as the biosafety level agents Currently there is no effective vaccine or therapeutic treatment against filoviral infection and pathogenes ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  9. Screening the Ribosome for New Target Sites

    SBC: NUBAD LLC            Topic: NIAID

    DESCRIPTION provided by applicant Nucleic acids are avenues for drug design both as therapeutics and as targets Here we propose to establish new methods for identifying antibiotic ribosome targets and lead compounds Targeting specific RNA such as rRNA which are involved in proliferation and survival of bacteria is a promising approach We are developing fast and low cost methods to screen s ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  10. Nitric Oxide Microfluidic Sensor

    SBC: CLINICAL SENSORS, INC.            Topic: NIAID

    DESCRIPTION provided by applicant This Small Business Innovation Research SBIR Phase I project aims to develop a microfluidic based nitric oxide NO sensor as an early sepsis risk assessment device Sepsis causes significant strain on the U S healthcare system consuming over $ billion annually due to extended hospital stays and significant morbidity and mortality Rapid diagnosis and in ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government